The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of intravesical anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin (BCG) therapy.
 
Jeffrey L. Wong
Patents, Royalties, Other Intellectual Property - Rockefeller University
 
David Knorr
Honoraria - Pfizer
Consulting or Advisory Role - Shoreline Biosciences
Research Funding - Pfizer
 
Karissa Whiting
No Relationships to Disclose
 
Venkatraman E. Seshan
No Relationships to Disclose
 
Eugene J. Pietzak
Honoraria - UpToDate
Consulting or Advisory Role - Chugai Pharma; Janssen; Merck; QED Therapeutics; Urogen pharma
Research Funding - Janssen
 
Timothy F. Donahue
No Relationships to Disclose
 
Eugene K. Cha
No Relationships to Disclose
 
Alvin C. Goh
Consulting or Advisory Role - Medtronic
Travel, Accommodations, Expenses - Medtronic
 
Robert Smith
Stock and Other Ownership Interests - Abbvie
 
Guido Dalbagni
No Relationships to Disclose
 
Marlena McGill
No Relationships to Disclose
 
Christian Hernandez
No Relationships to Disclose
 
Melissa McCarter
No Relationships to Disclose
 
Jonathan E. Rosenberg
Honoraria - Clinical Care Options; EMD Serono; Intellisphere; Medscape; MJH Life Sciences; Peerview; Physicans' Education Resource; Research To Practice; UpToDate
Consulting or Advisory Role - Alligator Bioscience; Astellas Pharma; AstraZeneca/MedImmune; Bayer; BioClin Therapeutics; Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Hengrui Pharmaceutical; Immunomedics; Infinity Pharmaceuticals; Janssen Oncology; Lilly; Merck; Mirati Therapeutics; Pfizer/EMD Serono; Pharmacyclics; QED Therapeutics; Roche/Genentech; Seagen; Tyra Biosciences
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); QED Therapeutics (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Predictor of platinum sensitivity (Inst)
 
Bernard H. Bochner
Consulting or Advisory Role - Olympus